Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan)

项目摘要/摘要 加州大学洛杉矶分校拟议的新的有指导的博士后培训计划--以患者为中心的结果研究 泌尿外科和妇科癌症培训(PCORT UroGynCan)，旨在为优秀的 博士后学者(包括MD、PhD、MD/PhD、ScD、DrPH和PharmD)专注于以下研究职业 开发和采用新的科学发现和创新，以改进设计、交付和 生殖系统癌症护理在个人、人群和卫生保健系统层面的结果。在……里面 当前全国卫生科学家数量下降的时代，特别是在临床提供者中，以及 扩大跨越不同现实世界环境的研究和实践之间的差距的必要性 卫生服务和系统以及人口结构多样化的人口，PCORT UroGynCan方案 将培训下一代研究人员，与和 回应卫生保健系统利益相关者的实际利益、需求和优先事项。为了照亮和 更好地理解实践和结果的差异以及T4翻译的障碍，跨学科 新T32计划的课程和指导实践研究机会交织在科学 27名多学科教师的专业知识和指导经验，他们致力于协作、团队和 在卫生服务和以患者为中心的结果、临床流行病学、 以及传播和实施，包括新出现的学习卫生系统领域。有四个人 每年的博士后实习生，每个人为期2年或可能为3年，实例化，用于劳动力 扩大、多学科的PCOR专职培训生队伍，既有经验也有新的吸引力 在泌尿和妇科肿瘤学研究方面，PCORT UroGynCan将利用局部相关资源 加州大学洛杉矶分校的教育、培训和职业发展计划的核心课程和保护时间 实现以下具体目标：(1)拓展循证多学科知识库 与生殖系统癌症护理有关的实践；(2)在以下方面提供教学和实践研究培训 快速和可持续地采用新的、经过验证的干预措施的智力和哲学基础 在更广泛的转化医学研究事业中；(3)培养学员的科学写作技能 演示文稿、出版物和赠款；(4)提供学术环境，使 作为成员和领导者成功、独立地从事科学事业所需的研究技能和经验 致力于改善患者和人群结果以及卫生系统的跨学科团队 在泌尿外科和妇科肿瘤学方面的表现；以及(5)模型研究-增强教学和 学员发展的指导技能，包括他们最终复制研究培训和职业生涯 卫生系统中的发展项目--利益攸关方合作改善生殖系统癌症 随着他们的职业生涯向稳定的、科学的独立方向发展，他们会受到关爱。

PROJECT SUMMARY/ABSTRACT The proposed new mentored postdoctoral training program at UCLA, Patient-Centered Outcomes Research Training in Urologic and Gynecologic Cancers (PCORT UroGynCan), is designed to prepare outstanding postdoctoral scholars (including MD, PhD, MD/PhD, ScD, DrPH, and PharmD) for research careers focused on development and uptake of new scientific discoveries and innovations that improve the design, delivery, and outcomes of reproductive system cancer care at the individual, population, and health care system levels. In the current era of declining numbers of health scientists nationwide, particularly among clinical providers, and of expanding necessity to bridge the gap between research and practice across diverse real-world settings of health services and systems as well as demographically diverse populations, the PCORT UroGynCan program will train next-generation researchers to formulate and conduct studies in close collaboration with and responsive to the actual interests, needs, and priorities of health care system stakeholders. To illuminate and better understand variation in practice and outcomes and the barriers of T4 translation, the interdisciplinary curriculum and mentored hands-on research opportunities of the new T32 program interweave the scientific expertise and mentoring experience of 27 multidisciplinary faculty who are committed to collaborative, team- based cross-training and research in health services and patient-centered outcomes, clinical epidemiology, and dissemination and implementation, including the newly emerging field of learning health systems. With four postdoctoral trainees per year, each for a 2- or potentially 3-year appointment, instantiating, for workforce expansion, multidisciplinary cohorts of PCOR-dedicated trainees both experienced in and newly attracted to research in urologic and gynecologic oncology, PCORT UroGynCan will leverage topically germane resources of education, training, and career development programs at UCLA for the core curriculum and protected time to achieve the following specific aims: (1) expand the multidisciplinary knowledge base of evidence-based practice as it relates to reproductive system cancer care; (2) provide didactic and hands-on research training in the intellectual and philosophical foundation of rapid and sustainable uptake of novel, proven interventions within the broader research enterprise of translational medicine; (3) develop trainees' scientific writing skills for presentations, publications, and grants; (4) provide an academic environment that enables development of the research skills and experience needed for successful, independent scientific careers as members and leaders of interdisciplinary teams dedicated to improving patient and population outcomes and health system performance in urologic and gynecologic oncology; and (5) model research-empowering teaching and mentoring skills for trainees' development, including their eventual replication of research training and career development programs in health system stakeholder-partnered improvements of reproductive system cancer care as their careers evolve into stable, scientific independence.